Shares in Aerie Pharmaceuticals (NSDQ:AERI) held steady today after the pharmaceutical company missed EPS estimates on Wall Street with its second quarter results.
The Irvine, Calif.-based company posted a net loss of -$28.4 million, or -82¢ per share, with its bottom line down -22.5% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Aerie Pharmaceuticals misses Q2 EPS by a penny appeared first on MassDevice.
from MassDevice http://ift.tt/2f9tjRR
Cap comentari:
Publica un comentari a l'entrada